Colorectal Cancer Diagnostic Methods: The Present and Future

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 May 17

PMID 37197135

Authors

Sai Sravya Gude

Rithik S Veeravalli

Bhuvanasai Vejandla

Sai Sreeya Gude

Tejaswi Venigalla

Venkateswarlu Chintagumpala

Affiliations

Soon will be listed here.

Abstract

To meet the needs of the colorectal cancer (CRC) patient population, colorectal cancer screening is continuously updated. The most significant advice is to start CRC screening exams at age 45 for people at average risk for CRC. CRC testing is divided into two categories: stool-based tests and visual inspections. High-sensitivity guaiac-based fecal occult blood testing, fecal immunochemical testing, and multitarget stool DNA testing are stool-based assays. Colon capsule endoscopy and flexible sigmoidoscopy are visualization examinations. There have been arguments about the importance of these tests in detecting and managing precursor lesions because of the lack of validation of screening results. Recent advancements in artificial intelligence and genetics have prompted the creation of newer diagnostic tests, which require validation in diverse populations and cohorts. In this article, we have discussed the present and emerging diagnostic tests.

Citing Articles

Diagnostic and prognostic significance of ALU-based cell-free DNA in colorectal cancer: a systematic review and meta-analysis.

Taghizadeh-Teymorloei M, Alizadeh L, Matin S, Jafari-Koshki T, Karimi A Front Oncol. 2024; 14:1398062.

PMID: 39169935 PMC: 11335620. DOI: 10.3389/fonc.2024.1398062.

Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune-Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI).

Menyhart O, Fekete J, Gyorffy B Int J Mol Sci. 2024; 25(15).

PMID: 39126008 PMC: 11312822. DOI: 10.3390/ijms25158441.

Design and evaluation of a colon cancer mobile application.

Sadeghi A, Salar S, Moghadam P, Cheraghpour M, Ghafouri R BMC Gastroenterol. 2024; 24(1):185.

PMID: 38807062 PMC: 11134615. DOI: 10.1186/s12876-024-03275-y.

Role of microRNA in colorectal carcinoma (CRC): a narrative review.

Sado A, Batool W, Ahmed A, Zafar S, Patel S, Mohan A Ann Med Surg (Lond). 2024; 86(1):308-318.

PMID: 38222721 PMC: 10783342. DOI: 10.1097/MS9.0000000000001494.

Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics.

Beniwal S, Lamo P, Kaushik A, Lorenzo-Villegas D, Liu Y, MohanaSundaram A Biosensors (Basel). 2023; 13(10).

PMID: 37887119 PMC: 10605407. DOI: 10.3390/bios13100926.

References

Bosch L, Melotte V, Mongera S, Daenen K, Coupe V, van Turenhout S . Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. Am J Gastroenterol. 2019; 114(12):1909-1918. PMC: 6903367. DOI: 10.14309/ajg.0000000000000445. View

Lee M, Loree J . Current and emerging biomarkers in metastatic colorectal cancer. Curr Oncol. 2019; 26(Suppl 1):S7-S15. PMC: 6878935. DOI: 10.3747/co.26.5719. View

Al-Joufi F, Setia A, Salem-Bekhit M, Sahu R, Alqahtani F, Widyowati R . Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches. Nanomaterials (Basel). 2022; 12(1). PMC: 8746463. DOI: 10.3390/nano12010169. View

Allison J, Fraser C, Halloran S, Young G . Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver. 2014; 8(2):117-30. PMC: 3964261. DOI: 10.5009/gnl.2014.8.2.117. View

Okugawa Y, Grady W, Goel A . Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology. 2015; 149(5):1204-1225.e12. PMC: 4589488. DOI: 10.1053/j.gastro.2015.07.011. View

Mousavinezhad M, Majdzadeh R, Akbari Sari A, Delavari A, Mohtasham F . The effectiveness of FOBT vs. FIT: A meta-analysis on colorectal cancer screening test. Med J Islam Repub Iran. 2016; 30:366. PMC: 4972062. View

Imperiale T, Ransohoff D, Itzkowitz S, Levin T, Lavin P, Lidgard G . Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014; 370(14):1287-97. DOI: 10.1056/NEJMoa1311194. View

Davidson K, Barry M, Mangione C, Cabana M, Caughey A, Davis E . Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021; 325(19):1965-1977. DOI: 10.1001/jama.2021.6238. View

Levin B, Brooks D, Smith R, Stone A . Emerging technologies in screening for colorectal cancer: CT colonography, immunochemical fecal occult blood tests, and stool screening using molecular markers. CA Cancer J Clin. 2003; 53(1):44-55. DOI: 10.3322/canjclin.53.1.44. View

10.

De la Paz E, Maganti N, Trifonov A, Jeerapan I, Mahato K, Yin L . A self-powered ingestible wireless biosensing system for real-time in situ monitoring of gastrointestinal tract metabolites. Nat Commun. 2022; 13(1):7405. PMC: 9715945. DOI: 10.1038/s41467-022-35074-y. View

11.

Shaukat A, Levin T . Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. 2022; 19(8):521-531. PMC: 9063618. DOI: 10.1038/s41575-022-00612-y. View

12.

Lu P, Zhu X, Song Y, Luo Y, Lin J, Zhang J . Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer. Dis Markers. 2022; 2022:7087885. PMC: 9271001. DOI: 10.1155/2022/7087885. View

13.

Macari M, Bini E . CT colonography: where have we been and where are we going?. Radiology. 2005; 237(3):819-33. DOI: 10.1148/radiol.2373041717. View

14.

Bretthauer M . Colorectal cancer screening. J Intern Med. 2011; 270(2):87-98. DOI: 10.1111/j.1365-2796.2011.02399.x. View

15.

Vuik F, Nieuwenburg S, Moen S, Spada C, Senore C, Hassan C . Colon capsule endoscopy in colorectal cancer screening: a systematic review. Endoscopy. 2021; 53(8):815-824. DOI: 10.1055/a-1308-1297. View

16.

Pickhardt P . Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection. Abdom Radiol (NY). 2016; 41(8):1441-4. PMC: 4974132. DOI: 10.1007/s00261-016-0798-4. View

17.

Jain S, Maque J, Galoosian A, Osuna-Garcia A, May F . Optimal Strategies for Colorectal Cancer Screening. Curr Treat Options Oncol. 2022; 23(4):474-493. PMC: 8989803. DOI: 10.1007/s11864-022-00962-4. View

18.

Kamel F, Eltarhoni K, Nisar P, Soloviev M . Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection. Cancers (Basel). 2022; 14(8). PMC: 9029324. DOI: 10.3390/cancers14081889. View

19.

Uraoka T, Hosoe N, Yahagi N . Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening?. Expert Rev Gastroenterol Hepatol. 2014; 9(2):129-32. DOI: 10.1586/17474124.2015.960397. View

20.

Hosoe N, Kamiya K, Hayashi Y, Sujino T, Ogata H, Kanai T . Current status of colon capsule endoscopy. Dig Endosc. 2020; 33(4):529-537. DOI: 10.1111/den.13769. View